Jacqueline Garcia, MD on oral maintenance therapy in AML/MDS patients - Poll - MDSpire

Jacqueline Garcia, MD on oral maintenance therapy in AML/MDS patients

Jacqueline Garcia, MD, of Dana-Farber Cancer Institute presented at #ASH24 data suggesting oral maintenance therapy with venetoclax and decitabine/cedazuridine after HCT is safe, feasible, and may reduce relapse rates in high-risk AML/MDS patients.

  • January 9, 2025

Share

Original Source(s)

Jacqueline Garcia, MD on oral maintenance therapy in AML/MDS patients

  • January 9, 2025

Related Content

Case Report: Gangrene after one dose of investigational stannic pentetate radiopharmaceutical

Delayed Platelet Engraftment and Ongoing Pulmonary Infection Following Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Case Study

The 46th annual meeting of the European society for blood and marrow transplantation: nurses group oral session (NO001-NO015)

  • December 11, 2020